Menu
  • Home
  • About Us
    • About 340B Report
    • Who We Are
    • Testimonials
    • Work With 340B Report
    • Contact
  • Subscribe Now
  • Document Center
  • Expert Directory
  • Events Calendar
  • Industry Insights
  • Sponsor/Advertise
  • Sign in
340B Report

340B Report

Category: Pharma Industry

BREAKING: AstraZeneca Raises the Ante in Drug Industry Push Against 340B Contract Pharmacy

In Breaking, Federal, Pharma Industry, RegulatoryAugust 17, 2020 Tom Mirga
SPONSORED BY


…

Read More »

Health Centers Seek Meeting With Merck About its 340B Contract Pharmacy Data Request

In Federal, Pharma Industry, Regulatory, Trade AssociationAugust 11, 2020 Tom Mirga
SPONSORED BY


A

…
Read More »

Sanofi Joins Growing List of Drug Companies Challenging 340B Contract Pharmacy

In Federal, Pharma Industry, RegulatoryJuly 28, 2020 Tom Mirga
SPONSORED BY


Note

…
Read More »

BREAKING: Hospitals and Other Providers Ask HHS to Halt Lilly and Merck’s Clampdowns on 340B; Companies Defend Their Positions

In Breaking, Federal, Pharma Industry, Regulatory, Trade AssociationJuly 17, 2020 Tom Mirga
SPONSORED BY


…

Read More »

340B ESP Wants to Be Pharma’s Go-to on 340B Duplicate Discounts. Kalderos Says Not So Fast.

In Federal, Other Industry, Pharma IndustryJuly 16, 2020 Tom Mirga
SPONSORED BY


A

…
Read More »

Eli Lilly Says It Doesn’t Have to Provide 340B-Priced Drugs to Contract Pharmacies

In Federal, Pharma Industry, RegulatoryJuly 7, 2020 Tom Mirga
SPONSORED BY


A

…
Read More »

340B Drug Manufacturer Audits: A Q&A with HRSA

In Federal, Pharma Industry, RegulatoryJune 18, 2020 Tom Mirga
SPONSORED BY


A

…
Read More »

HRSA Takes Step to Improve 340B Pricing Consistency

In Federal, Pharma Industry, RegulatoryJune 16, 2020 Tom Mirga
SPONSORED BY


A

…
Read More »

DOJ Says Mallinckrodt Owes Medicaid Hundreds of Millions in Rebates, but Is Silent About 340B Overcharges

In Federal, Judicial, Pharma Industry, RegulatoryMarch 5, 2020 Tom Mirga

If Mallinckrodt settles charges it evaded
…
Read More »

340B Providers Could Face Drug Access Challenges Due to Coronavirus

In Federal, Pharma Industry, RegulatoryMarch 3, 2020 Tom Mirga

An electron microscope image of SARS-CoV2
…
Read More »

Posts navigation

1 … 4 5 6 7

Site Sidebar

Categories

  • Breaking
  • Federal
  • Judicial
  • Legislative
  • Non-Governmental
  • Other Industry
  • Pharma Industry
  • Regulatory
  • Research/Reports
  • State
  • Trade Association
  • Uncategorized

Recent Posts

  • Our First Issue Behind Our Paywall
  • Gilead Adjusts Planned Change in its Patient Assistance After HIV Community Pushes Back
  • HHS Asks Court to Toss Out Hospitals’ 340B Contract Pharmacy Lawsuit
  • View From Capitol Hill: An Inside Look at the Latest Developments Shaping the 340B Program
  • Senate Finance Report Might Shed Light on Insulin Manufacturers’ 340B Contract Pharmacy Actions

Site Footer

Terms of Use Privacy Policy